SEC Filings

 
SEC Filings
Date Filing Description View
Apr 28, 2017 8-K/A amended current report HTML PDF XLS
137.7 KB
Add to Briefcase
Apr 27, 2017 8-K current report HTML PDF XLS
178.7 KB
Add to Briefcase
Apr 26, 2017 8-K current report HTML PDF XLS
140.5 KB
Add to Briefcase
Apr 24, 2017 4 friedman, cathy HTML PDF XLS
152.0 KB
Add to Briefcase
Apr 24, 2017 4 duncan, barbara gayle HTML PDF XLS
152.0 KB
Add to Briefcase
Apr 24, 2017 4 lepore, patrick g HTML PDF XLS
151.6 KB
Add to Briefcase
Apr 24, 2017 4 tyree, james l HTML PDF XLS
151.9 KB
Add to Briefcase
Apr 24, 2017 4 waltrip, william h HTML PDF XLS
152.0 KB
Add to Briefcase
Apr 24, 2017 4 pepe, paul HTML PDF XLS
152.0 KB
Add to Briefcase
Apr 20, 2017 DFAN14A definitive proxy statement HTML PDF XLS
149.6 KB
Add to Briefcase
1
...
NextLast
= add PDF file to Briefcase

Innoviva NASDAQ: INVA

$11.79 0.81 (6.39%) 04/28/17 4:15 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.